KR960000893A - 세팔로스포린 염의 정제 방법 - Google Patents

세팔로스포린 염의 정제 방법 Download PDF

Info

Publication number
KR960000893A
KR960000893A KR1019950015338A KR19950015338A KR960000893A KR 960000893 A KR960000893 A KR 960000893A KR 1019950015338 A KR1019950015338 A KR 1019950015338A KR 19950015338 A KR19950015338 A KR 19950015338A KR 960000893 A KR960000893 A KR 960000893A
Authority
KR
South Korea
Prior art keywords
isopropoxycarbonyloxy
carboxylic acid
hydroxyiminoacetamido
cepem
aminothiazol
Prior art date
Application number
KR1019950015338A
Other languages
English (en)
Inventor
루데슈어 요하네르
푸커 라이너
볼프 지그프리트
Original Assignee
클리페 에스. 모리스. 한스 루돌프 하우스
바이오케미 게젤샤프트 엠.베.하.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클리페 에스. 모리스. 한스 루돌프 하우스, 바이오케미 게젤샤프트 엠.베.하. filed Critical 클리페 에스. 모리스. 한스 루돌프 하우스
Publication of KR960000893A publication Critical patent/KR960000893A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 구조식(I)의 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설폰산 염, 다른 염의 제조에 있어서의 이의 용도 및 이를 함유하는 약제학적 조성물에 관한 것이다.

Description

세팔로스포린 염의 정제 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설폰산 염.
  2. 결정성인, 다음 구조식(I)의 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설포네이트.
  3. 제2하엥 있어서, X-선 데이터 중에 28.247;9.473;5.014;4.942;3.994중 하낭 이상의 d-값(A)을 갖는 화합물.
  4. 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 상이한 염을 제조하는 데 있어서의,7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설폰산 염의 용도.
  5. 적절한 염 형성제를 사용하여 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설폰산 염을 상이한 염으로 전환시킴을 포함하여,7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 염을 제조하는 방법.
  6. 활성 성분으로서 7-[2-(2-아미노티아졸-4-일)-2-(Z)--하이드록시이미노아세트아미도]-3-N,N-디메틸카바모일옥시메틸-3-세펨-4-카복실산(이소프로폭시카보닐옥시)에틸에스테르의 p-톨루엔설폰산염을 함유하는 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950015338A 1994-06-14 1995-06-12 세팔로스포린 염의 정제 방법 KR960000893A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA1181/94 1994-06-14
AT0118194A AT401651B (de) 1994-06-14 1994-06-14 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-

Publications (1)

Publication Number Publication Date
KR960000893A true KR960000893A (ko) 1996-01-25

Family

ID=3508369

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950015338A KR960000893A (ko) 1994-06-14 1995-06-12 세팔로스포린 염의 정제 방법

Country Status (5)

Country Link
US (2) US5659030A (ko)
EP (1) EP0687676A1 (ko)
JP (1) JP2936052B2 (ko)
KR (1) KR960000893A (ko)
AT (1) AT401651B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
KR100463920B1 (ko) * 2002-10-18 2004-12-30 제일약품주식회사 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
AU2006242535B2 (en) * 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
AU2009203598B2 (en) * 2008-01-08 2013-09-26 Merck Sharp & Dohme Llc Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3- yl]phenyl} -2H-indazole-7-carboxamide
TW201211036A (en) * 2010-06-17 2012-03-16 Kyowa Hakko Kirin Co Ltd Useful salts of indazole derivative
AR103406A1 (es) * 2015-01-30 2017-05-10 Lilly Co Eli Sal de tosilato

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
IL113744A (en) * 1990-11-09 1998-06-15 Eisai Co Ltd History of 3-tufts and their preparation
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
JPH05230068A (ja) * 1992-02-07 1993-09-07 Kyoto Yakuhin Kogyo Kk ３−ジ置換カルバモイルオキシメチルセファロスポリン化合物、その製造法および中間体化合物

Also Published As

Publication number Publication date
US5861508A (en) 1999-01-19
JP2936052B2 (ja) 1999-08-23
EP0687676A1 (en) 1995-12-20
AT401651B (de) 1996-11-25
JPH083170A (ja) 1996-01-09
US5659030A (en) 1997-08-19

Similar Documents

Publication Publication Date Title
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
IT1152287B (it) Pirrolidin-derivati
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
KR960000893A (ko) 세팔로스포린 염의 정제 방법
FI831070A0 (fi) Salicylsyraderivat, foerfarande foer deras framstaellning, pao dessa foereningar baserade farmaceutprodukter och deras anvaendning
KR900001715A (ko) Bu-3608 유도체
KR840007731A (ko) 세팔로스포린 화합물의 제조방법
EP0357089A3 (en) Novel cephem compound as an antimicrobial agent and its preparation
FI833200A (fi) Isokinolinderivat, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutpreparat och deras anvaendning
KR950700293A (ko) 세로토닌작동성의 에르골린 유도체(Serotoninergic ergoline derivatives)
PH20392A (en) Pyridobenzodiazepinones pharmaceutical compositions thereof and method of use thereof
DK225985D0 (da) Cephalosporiner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
MX9207204A (es) Preparado farmaceutico y procedimiento para su fabricacion.
KR910000748A (ko) 결정성 세펨산 부가염 및 이의 제조 방법
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
KR850000456A (ko) 세팔로스포린 에스테르의 제조방법
KR930703275A (ko) 벤조옥사디논유도체
KR920019734A (ko) 페닐술포닐알칸산 화합물
JPS5515482A (en) Imidazoline compound and medical composition
DE3168174D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
FI922518A (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application